| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer | Senior Vp-corporate Operations
1 company
Cruse Michael is a Chief Operating Officer at OKUR. Recent filings cover 7 purchases and 0 sales. Those positions are worth an estimated $56K at current prices.
Our model assigns Cruse Michael a middling insider score of 59/100, based on 5 past trades. Over a 12-month horizon, 80.0% of those trades were profitable, with an average 12-month return of +61.2%.
Cruse Michael's largest disclosed position is in OKUR as Chief Operating Officer, worth about $56K. Net of sales, the recent Form 4 record there shows accumulation of 17,255 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 1, 2022 | OKUR Onkure Therapeutics, Inc. | Chief Operating Officer | Buy | 7,500 | $3.39 | $25,447.50 | +121.0% | -36.3% | +80.6% | |
| Aug 31, 2022 | OKUR Onkure Therapeutics, Inc. | Chief Operating Officer | Buy | 7,255 | $3.20 | $23,243.39 | +11.1% | -30.5% | +91.1% | |
| Aug 25, 2021 | OKUR Onkure Therapeutics, Inc. | Senior Vp-corporate Operations | Buy | 2,500 | $7.45 | $18,616.00 | New | +13.2% | -52.4% |